ENGEN BIO
Mark Baer has a PhD in Biochemistry from the University of North Carolina at Chapel Hill and a BA in Biochemistry from Cornell University. Mark has held positions such as Vice President of Research at ENGEN BIO since January 2012 and Associate Director at KaloBios Pharmaceuticals Inc from January 2001 to September 2011.
This person is not in any offices
ENGEN BIO
EnGen is an early-stage biotechnology company pioneering a new approach to preventing and treating influenza.